Free tool
Stocks above their 200-day average
We cover 673 companies trading above their own 200-day average. The median market value in the group is $225.00M. Across the group, the median move over the past trading day is 0.00%. 100% of the 673 with a 200-day average trade above it. Price change over the past year runs from −26.3% to +188.0% across the middle 80 percent of the group, with a median of +24.5%. Across the group, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
673 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LILY34.SA | Eli Lilly and Company | 211.20 BRL | +0.76% | +9.59% | +59.83% |
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% |
| LLY | Eli Lilly and Company | $1,189.41 | −2.56% | +10.47% | +62.80% |
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% |
| JNJB34.SA | Johnson & Johnson | 92.80 BRL | +2.16% | +24.99% | +47.82% |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% |
| ABBV34.SA | AbbVie Inc. | 84.88 BRL | −0.29% | +9.50% | +21.88% |
| MRCK34.SA | Merck & Co., Inc. | 101.37 BRL | +20.05% | +39.73% | +81.07% |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| RHO.DE | Roche Holding AG | 405.40 EUR | +2.01% | +14.00% | +41.42% |
| N1VS34.SA | Novartis AG | 81.76 BRL | +1.49% | +11.09% | +20.04% |
| NOT.DE | Novartis AG | 136.70 EUR | −1.56% | +19.69% | +28.89% |
| NVS | Novartis AG | $157.54 | −1.45% | +17.18% | +27.93% |
| AMGN34.SA | Amgen Inc. | 81.32 BRL | +13.94% | +69.69% | +47.79% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | 67.15 BRL | +9.49% | −0.22% | +22.22% |
| NVO.WA | Novo Nordisk A/S | 175.12 PLN | −10.34% | −1.45% | −9.22% |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% |
| N1VO34.SA | Novo Nordisk A/S | 30.41 BRL | −6.72% | −12.87% | −17.86% |
| NVO | Novo Nordisk A/S | $47.19 | −7.40% | −6.62% | −13.32% |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% |
| GHRS | GH Research PLC | $29.01 | +3.76% | +119.11% | +112.84% |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% |
| PIII | P3 Health Partners Inc. | $9.92 | −5.70% | +183.43% | +26.37% |
| PGNY | Progyny, Inc. | $26.37 | −14.27% | +2.45% | +14.55% |
| FLRY3.SA | Fleury S.A. | 18.66 BRL | +9.38% | +25.83% | +37.82% |
| TSHA | Taysha Gene Therapies, Inc. | $6.02 | +10.26% | +14.67% | +102.69% |
| EMBLA.CO | Embla Medical hf. | 30.15 DKK | +5.05% | −5.78% | −6.94% |
| IMCR | Immunocore Holdings plc | $37.12 | +10.77% | +9.89% | +13.69% |
| ASTH | Astrana Health, Inc. | $38.61 | +1.69% | +53.09% | +23.71% |
| SNDA | Sonida Senior Living, Inc. | $39.67 | −7.89% | +24.24% | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $13.19 | +21.12% | +43.21% | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $30.39 | +3.30% | +39.28% | +804.46% |
| SEPN | Septerna, Inc. | $40.25 | +18.49% | +43.85% | +218.81% |
| NEU.AX | Neuren Pharmaceuticals Limited | 20.59 AUD | +20.20% | +8.88% | +5.54% |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | 82.40 EUR | +8.42% | +52.87% | +53.42% |
| PSNL | Personalis, Inc. | $17.08 | +43.77% | +117.58% | +257.32% |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% |
| ETON | Eton Pharmaceuticals, Inc. | $62.62 | +34.20% | +285.12% | +262.38% |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% |
| FTRE | Fortrea Holdings Inc. | $18.53 | −10.48% | +10.23% | +105.20% |
| ALVO | Alvotech | $4.91 | +58.39% | −1.80% | −38.85% |
| ALVO-SDB.ST | Alvotech | 46.45 SEK | +33.67% | +1.57% | −39.57% |
| ANAB | AnaptysBio, Inc. | $58.00 | +11.30% | +93.55% | +326.47% |
| CLARI.PA | Clariane SE | 4.01 EUR | −0.89% | +2.14% | −6.95% |
| 7716.T | Nakanishi Inc. | 3,155.00 JPY | +5.94% | +58.15% | +52.27% |
| BCAX | Bicara Therapeutics Inc. | $24.73 | −8.00% | +50.98% | +105.74% |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% |
| AGL | agilon health, inc. | $95.74 | −3.43% | +468.19% | +194.58% |
| PYC.AX | PYC Therapeutics Limited | 2.25 AUD | +38.46% | +35.95% | +74.42% |
| ARDT | Ardent Health, Inc. | $11.23 | −2.09% | +29.98% | −11.64% |
| XERS | Xeris Biopharma Holdings, Inc. | $8.68 | +5.34% | +18.10% | +8.64% |
| ABSI | Absci Corporation | $9.22 | +29.31% | +155.40% | +261.57% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | 57.60 BRL | +8.15% | +25.08% | +298.89% |
| HCSG | Healthcare Services Group, Inc. | $22.91 | −3.54% | +32.05% | +47.05% |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% |
| KMTS | Kestra Medical Technologies, Ltd. | $26.57 | +11.36% | +8.94% | +47.61% |
| LBRX | LB Pharmaceuticals Inc | $48.17 | +37.85% | +135.64% | +178.41% |
| AVBP | ArriVent BioPharma, Inc. | $31.14 | +3.87% | +49.71% | +62.10% |
| CNMD | CONMED Corporation | $50.48 | +14.08% | +24.58% | −6.91% |
| NVAX | Novavax, Inc. | $9.21 | +24.97% | +29.17% | +21.50% |
| REPL | Replimune Group, Inc. | $15.88 | +196.82% | +78.43% | +187.16% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $21.37 | +20.33% | −0.84% | +74.45% |
| RDC.DE | Redcare Pharmacy NV | 62.05 EUR | −10.46% | −6.06% | −23.82% |
| INNV | InnovAge Holding Corp. | $11.04 | −6.52% | +112.72% | +178.79% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| AZTA | Azenta, Inc. | $33.57 | +16.04% | +0.54% | +11.16% |
| OMDA | Omada Health, Inc. | $23.96 | +17.28% | +60.81% | +2.74% |
| SDGR | Schrödinger, Inc. | $19.47 | +27.34% | +8.29% | −1.62% |
| ENOV | Enovis Corporation | $25.25 | −14.46% | −4.75% | −18.60% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| ORIC | ORIC Pharmaceuticals, Inc. | $13.91 | +16.79% | +70.26% | +35.58% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $36.53 | +33.22% | +120.19% | +786.65% |
| MGTX | MeiraGTx Holdings plc | $14.92 | +26.23% | +91.04% | +100.54% |
| GDS.PA | Ramsay Générale de Santé SA | 10.95 EUR | −0.45% | +17.24% | +9.50% |
| OMER | Omeros Corporation | $18.22 | +61.52% | +11.23% | +328.71% |
| JBIO | Jade Biosciences, Inc. | $21.33 | +8.27% | +50.64% | +168.30% |
| DRTS | Alpha Tau Medical Ltd. | $14.96 | +29.52% | +209.73% | +343.92% |
| 3148.T | Create SD Holdings Co., Ltd. | 3,410.00 JPY | −3.26% | +3.54% | +1.90% |
| 9627.T | Ain Holdings Inc. | 6,142.00 JPY | −2.57% | −5.73% | +2.85% |
| NUTX | Nutex Health Inc. | $195.92 | +31.46% | +32.21% | +118.22% |
| PNTG | The Pennant Group, Inc. | $38.28 | −8.90% | +37.55% | +56.31% |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% |
| UPR.L | Uniphar plc | 370.00 GBP | −1.33% | +23.75% | +6.94% |
| AMN | AMN Healthcare Services, Inc. | $34.24 | −1.30% | +126.46% | +70.26% |
| CRON.TO | Cronos Group Inc. | 4.95 CAD | +23.75% | +34.15% | +39.83% |
| CRON | Cronos Group Inc. | $3.55 | +24.56% | +31.48% | +38.67% |
| IART | Integra LifeSciences Holdings Corporation | $16.88 | −14.57% | +40.55% | +13.52% |
| VOR | Vor Biopharma Inc. | $23.67 | +18.35% | +103.35% | −40.82% |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% |
| 4544.T | H.U. Group Holdings, Inc. | 3,634.00 JPY | +1.08% | +8.30% | +2.77% |
| SANA | Sana Biotechnology, Inc. | $4.16 | +26.44% | −0.72% | +23.44% |
| GDRX | GoodRx Holdings, Inc. | $3.65 | +16.99% | +32.73% | −18.89% |
| CERT | Certara, Inc. | $8.22 | +3.92% | −5.95% | −25.07% |
| 2175.T | SMS Co., Ltd. | 2,391.00 JPY | +0.80% | +80.27% | +54.71% |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.73 | +10.67% | +101.23% | +167.82% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | 3,915.00 JPY | −7.56% | +9.34% | +34.65% |
| 6523.T | PHC Holdings Corporation | 1,527.00 JPY | +36.71% | +37.93% | +58.42% |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% |
| AVNS | Avanos Medical Inc | $24.99 | +0.04% | +123.52% | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $78.27 | −0.92% | +0.55% | −5.67% |
| KURA | Kura Oncology, Inc. | $13.06 | +40.28% | +26.37% | +66.16% |
| JANX | Janux Therapeutics, Inc. | $18.89 | +25.93% | +38.39% | −19.10% |
| SVRA | Savara Inc. | $5.61 | +5.25% | −0.53% | +70.52% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | 14.70 EUR | +13.08% | +15.81% | +24.49% |
| 2160.T | GNI Group Ltd. | 2,879.00 JPY | +25.17% | +25.72% | +8.36% |
| OPK | OPKO Health, Inc. | $1.51 | −8.48% | +18.90% | +6.34% |
| 7476.T | AS ONE Corporation | 2,473.00 JPY | −4.18% | +4.62% | +2.31% |
| PHIL.MI | Philogen S.p.A. | 23.85 EUR | +1.06% | +6.10% | +4.75% |
| AVTX | Avalo Therapeutics, Inc. | $20.55 | +5.28% | +20.74% | +112.95% |
| SLDB | Solid Biosciences Inc. | $9.72 | +21.96% | +78.35% | +72.95% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $2.31 | −1.28% | +102.63% | +104.42% |
| CSTL | Castle Biosciences, Inc. | $34.08 | +42.65% | −11.57% | +52.96% |
| ABUS | Arbutus Biopharma Corporation | $5.19 | +17.69% | +8.81% | +42.19% |
| GUBRA.CO | Gubra A/S | 402.40 DKK | +6.23% | −24.64% | +4.79% |
| GXI.DE | Gerresheimer AG | 25.58 EUR | −9.23% | −7.99% | −39.73% |
| PCRX | Pacira BioSciences, Inc. | $25.90 | −3.39% | +5.89% | −0.88% |
| CADL | Candel Therapeutics, Inc. | $13.28 | +37.19% | +144.12% | +124.70% |
| IMMX | Immix Biopharma, Inc. | $14.07 | +66.71% | +159.12% | +617.86% |
| GERN | Geron Corporation | $1.53 | +5.52% | +15.91% | +8.51% |
| HELP | Cybin D/B/A Helus Pharma | $13.63 | +79.34% | +64.61% | +77.71% |
| 7730.T | Mani, Inc. | 1,607.00 JPY | +5.38% | +10.38% | +29.48% |
| DSGN | Design Therapeutics, Inc. | $15.59 | +31.34% | +71.32% | +194.71% |
| BVS | Bioventus Inc. | $13.97 | +5.75% | +93.76% | +86.52% |
| NEU.WA | NEUCA S.A. | 758.00 PLN | +1.34% | −9.22% | +15.02% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% |
| CLYM | Climb Bio Inc | $16.08 | +30.84% | +328.80% | +603.72% |
| PHN.MI | Pharmanutra S.p.A. | 81.50 EUR | −1.81% | +53.54% | +70.46% |
| ACRS | Aclaris Therapeutics, Inc. | $6.19 | +16.14% | +114.93% | +240.11% |
| CBLL | CeriBell, Inc. | $23.45 | +31.52% | +10.09% | +102.16% |
| ANL | Adlai Nortye Ltd. | $15.06 | +18.68% | +991.30% | +791.12% |
| 7780.T | Menicon Co., Ltd. | 1,884.00 JPY | +4.09% | +21.53% | +54.36% |
| TALK | Talkspace, Inc. | $5.25 | +0.77% | +49.57% | +93.73% |
| BBNX | Beta Bionics, Inc. | $19.34 | +22.41% | −33.88% | +1.95% |
| AVR | Anteris Technologies Global Corp. | $8.95 | +9.55% | +81.91% | +144.54% |
| RIGL | Rigel Pharmaceuticals, Inc. | $46.48 | +20.73% | +11.12% | +16.99% |
| INMD | InMode Ltd. | $14.93 | −3.49% | +0.88% | −1.71% |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +3.64% | +4.03% | −10.28% |
| SIBN | SI-BONE, Inc. | $19.43 | +8.37% | −1.82% | +17.12% |
| AVR.AX | Anteris Technologies Global Corp. | 12.28 AUD | +3.63% | +64.83% | +106.39% |
| FDMT | 4D Molecular Therapeutics, Inc. | $15.56 | +57.97% | +112.57% | +140.87% |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% |
| SLN | Silence Therapeutics plc | $13.53 | +17.14% | +120.00% | +160.19% |
| HSTM | HealthStream, Inc. | $28.76 | −0.31% | +26.59% | +1.86% |
| SFL.MI | Safilo Group S.p.A. | 1.85 EUR | +14.02% | −5.33% | +20.65% |
| AMS.L | Advanced Medical Solutions Group plc | 281.50 GBP | +0.36% | +29.14% | +38.01% |
| GNFT.PA | Genfit S.A. | 14.30 EUR | +5.30% | +172.38% | +310.45% |
| APOTEA.ST | Apotea AB (publ) | 75.30 SEK | +1.41% | −16.05% | −26.38% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $3.18 | 0.00% | −14.29% | +45.87% |
| NVCT | Nuvectis Pharma, Inc. | $25.00 | +26.14% | +193.77% | +275.94% |
| EIQ.AX | Echo IQ Limited | 1.53 AUD | +21.03% | +498.04% | +609.30% |
| WELL.TO | WELL Health Technologies Corp. | 4.38 CAD | +9.23% | +8.15% | −8.18% |
| ARJO-B.ST | Arjo AB (publ) | 28.38 SEK | +4.11% | −6.88% | −15.25% |
| AURA | Aura Biosciences, Inc. | $7.73 | +9.65% | +45.85% | +20.03% |
| UU8.F | Neurogene Inc. | 33.20 EUR | +21.17% | +29.18% | +165.60% |
| STTK | Shattuck Labs, Inc. | $7.90 | +15.84% | +112.94% | +690.00% |
| VREX | Varex Imaging Corporation | $18.48 | +66.04% | +58.63% | +61.40% |
| SNT.WA | Synektik Spólka Akcyjna | 338.40 PLN | −5.58% | +21.82% | +53.07% |
| NGNE | Neurogene Inc. | $38.41 | +15.62% | +90.53% | +95.02% |
| MNPR | Monopar Therapeutics Inc. | $113.72 | +4.24% | +72.28% | +226.69% |
| 4588.T | Oncolys BioPharma Inc. | 4,080.00 JPY | +66.46% | +173.09% | +539.50% |
| SOPH | SOPHiA GENETICS SA | $8.53 | +53.14% | +82.66% | +156.16% |
| ASMB | Assembly Biosciences, Inc. | $35.42 | +38.52% | +4.95% | +36.81% |
| DHT-UN.TO | DRI Healthcare Trust | 17.63 CAD | −0.51% | +10.64% | +27.29% |
| XOMA | XOMA Royalty Corp | $40.17 | 0.00% | +43.52% | +19.27% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $4.29 | +12.89% | +0.47% | +240.48% |
| ALLO | Allogene Therapeutics, Inc. | $2.04 | +22.89% | +51.11% | +75.86% |
| C2RS34.SA | CRISPR Therapeutics AG | 36.81 BRL | +20.41% | +2.36% | +0.85% |
| TECX | Tectonic Therapeutic, Inc. | $35.97 | +20.70% | +72.02% | +35.43% |
| OABI | OmniAb, Inc. | $4.81 | +144.16% | +155.85% | +198.76% |
| ZVRA | Zevra Therapeutics, Inc. | $11.74 | +20.66% | +40.77% | +25.43% |
| 7575.T | Japan Lifeline Co., Ltd. | 1,565.00 JPY | +7.93% | +0.59% | +12.02% |
| GUD.TO | Knight Therapeutics Inc. | 9.76 CAD | −0.81% | +65.14% | +50.39% |
| DHT-U.TO | DRI Healthcare Trust | $12.56 | +0.88% | +6.68% | +27.68% |
| AQST | Aquestive Therapeutics, Inc. | $5.39 | +43.35% | −16.43% | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% |
| CBIO | Crescent Biopharma, Inc. | $18.02 | +9.61% | +62.64% | +26.46% |
| LBIRD.PA | Lumibird SA | 25.80 EUR | −1.53% | +23.06% | +57.43% |
| CRMD | CorMedix Inc. | $8.39 | +14.15% | −31.00% | −40.66% |
| PRME | Prime Medicine, Inc. | $3.58 | +15.86% | +1.42% | +4.37% |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% |
| 4565.T | Nxera Pharma Co., Ltd. | 1,109.00 JPY | +27.47% | +31.40% | +22.68% |
| VSTM | Verastem, Inc. | $7.39 | +18.62% | +2.21% | −20.45% |
| CTNM | Contineum Therapeutics, Inc. | $17.02 | +20.20% | +49.43% | +70.03% |
| KIDS | OrthoPediatrics Corp. | $24.03 | +21.12% | +36.85% | +11.10% |
| CTEV | Claritev Corporation | $37.57 | +65.73% | +10.86% | −47.71% |
| 6197.T | Solasto Corporation | 1,118.00 JPY | +0.63% | +30.15% | +136.68% |
| AUTL | Autolus Therapeutics plc | $2.33 | +60.69% | +24.60% | +48.41% |
| 3034.T | Qol Holdings Co., Ltd. | 2,497.00 JPY | +12.88% | +21.60% | +24.35% |
| WEAV | Weave Communications, Inc. | $7.31 | +6.10% | +1.95% | −5.68% |
| EOLS | Evolus, Inc. | $8.78 | +41.16% | +30.65% | +15.83% |
| ARTV | Artiva Biotherapeutics, Inc. | $11.77 | +11.78% | +178.25% | +259.94% |
| BWAY | BrainsWay Ltd. | $14.30 | −7.68% | +48.26% | +87.42% |
| ZURA | Zura Bio Limited | $5.99 | +8.12% | +7.93% | +177.31% |
| DCTH | Delcath Systems, Inc. | $16.40 | +41.99% | +64.82% | +49.91% |
| OVID | Ovid Therapeutics Inc. | $2.88 | +22.03% | +63.64% | +128.57% |
| EVH | Evolent Health, Inc. | $4.92 | +31.55% | +26.48% | −48.86% |
| ENTX | Entera Bio Ltd. | $3.19 | −2.15% | +80.23% | +62.76% |
| CERS | Cerus Corporation | $2.74 | −6.16% | +39.09% | +109.16% |
| KYTX | Kyverna Therapeutics, Inc. | $8.61 | +14.95% | −1.82% | +133.33% |
| CABA | Cabaletta Bio, Inc. | $3.25 | +19.05% | +47.06% | +116.67% |
| SRTA | Strata Critical Medical, Inc. | $6.12 | +20.24% | +24.14% | +33.62% |
| AYA.AX | Artrya Limited | 5.03 AUD | +5.45% | −0.79% | +157.95% |
| 2664.T | Cawachi Limited | 3,760.00 JPY | +8.20% | +28.43% | +38.25% |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% |
| CCCC | C4 Therapeutics, Inc. | $4.24 | +19.44% | +119.69% | +64.34% |
| 7979.T | Shofu Inc. | 2,321.00 JPY | +6.76% | +30.43% | +21.34% |
| 4480.T | Medley, Inc. | 2,713.00 JPY | +30.12% | +15.94% | +9.22% |
| TOI | Starling Oncology Inc | $6.20 | +25.25% | +68.94% | +79.19% |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +4.43% |
| 3151.T | Vital KSK Holdings, Inc. | 1,670.00 JPY | −2.51% | +21.29% | +40.44% |
| CLPT | ClearPoint Neuro, Inc. | $16.37 | +12.66% | +16.68% | +53.85% |
| IMR.AX | Imricor Medical Systems, Inc. | 1.95 AUD | +0.78% | +18.96% | +40.43% |
| SENS | Senseonics Holdings, Inc. | $9.34 | +90.22% | +58.57% | +0.43% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | 0.81 EUR | +8.00% | +386.49% | +1198.08% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $7.43 | +21.80% | −1.85% | +40.72% |
| EDIT | Editas Medicine, Inc. | $3.18 | +21.37% | +55.12% | +19.10% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | 10.28 CAD | +20.23% | −1.72% | +43.78% |
| NRC | NRC Health | $22.00 | −1.52% | +23.14% | +45.92% |
| RZLT | Rezolute, Inc. | $5.04 | +2.44% | +132.79% | −30.00% |
| KMDA | Kamada Ltd. Ordinary Shares | $8.38 | +18.70% | +22.82% | +21.09% |
| QTTB | Q32 Bio Inc. | $16.18 | +2.99% | +370.35% | +840.70% |
| PBYI | Puma Biotechnology, Inc. | $9.16 | +14.93% | +58.75% | +79.61% |
| SGHT | Sight Sciences, Inc. | $8.37 | +57.92% | +11.90% | +97.87% |
| KSI.TO | kneat.com, inc. | 6.50 CAD | +0.46% | +30.52% | +19.93% |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $15.83 | +175.30% | +153.28% | −8.44% |
| MCTA | Charming Medical Limited | $29.36 | 0.00% | 0.00% | +319.36% |
| BNTC | Benitec Biopharma Inc. | $12.88 | +8.33% | +2.34% | +0.16% |
| AVIR | Atea Pharmaceuticals, Inc. | $5.51 | +22.17% | +58.33% | +53.06% |
| CARL | Carlsmed, Inc. | $16.18 | +31.44% | +39.12% | +16.40% |
| AVCT.L | Avacta Group Plc | 69.50 GBP | +0.72% | +20.87% | +26.36% |
| LRMR | Larimar Therapeutics, Inc. | $4.17 | +8.88% | +20.17% | +6.92% |
| FRX.TO | Fennec Pharmaceuticals Inc. | 17.00 CAD | +21.86% | +63.30% | +36.00% |
| MASS | 908 Devices Inc. | $10.37 | +47.51% | +103.73% | +64.60% |
| CCRN | Cross Country Healthcare Inc | $13.25 | 0.00% | +64.39% | +0.38% |
| FENC | Fennec Pharmaceuticals Inc. | $12.17 | +22.43% | +58.46% | +34.62% |
| GALT | Galectin Therapeutics Inc. | $4.15 | +22.42% | +2.47% | +4.27% |
| XFOR | X4 Pharmaceuticals, Inc. | $4.17 | +6.11% | +7.20% | −1.42% |
| ENTA | Enanta Pharmaceuticals, Inc. | $14.15 | +12.21% | −1.87% | +65.89% |
| CEVI.ST | CellaVision AB (publ) | 164.00 SEK | +7.47% | +10.88% | −5.28% |
| LNA.PA | LNA Santé SA | 33.90 EUR | −2.87% | +38.37% | +11.88% |
| M12.DE | M1 Kliniken AG | 18.36 EUR | −2.86% | +1.10% | +37.84% |
| RCKT | Rocket Pharmaceuticals, Inc. | $3.66 | +16.56% | +5.78% | +10.24% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | 2,623.00 JPY | +5.13% | +30.89% | +27.04% |
| FHTX | Foghorn Therapeutics Inc. | $6.69 | +30.41% | +28.90% | +23.66% |
| TBRG | TruBridge Inc | $26.24 | 0.00% | +25.55% | +30.42% |
| IPSC | Century Therapeutics, Inc. | $2.14 | +4.39% | +115.08% | +315.53% |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% |
| TKNO | Alpha Teknova, Inc. | $7.22 | +41.85% | +85.13% | +62.25% |
| AUNA | Auna SA | $5.23 | +0.58% | +9.87% | −16.85% |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | 1.92 BRL | +214.75% | −29.41% | −33.79% |
| VOX.WA | Voxel S.A. | 134.20 PLN | +6.85% | +10.36% | −18.11% |
| CGS.AX | Cogstate Limited | 3.20 AUD | +22.88% | +39.52% | +85.76% |
| 368A.T | KITAZATO CORPORATION | 1,495.00 JPY | +7.55% | −1.89% | −1.33% |
| ACL.AX | Australian Clinical Labs Limited | 2.81 AUD | +15.64% | +4.75% | +5.46% |
| SLP | Simulations Plus, Inc. | $18.41 | +0.44% | +1.66% | +28.20% |
| AGEN | Agenus Inc. | $8.25 | +25.00% | +155.42% | +81.72% |
| PALI | Palisade Bio, Inc. | $2.13 | +5.45% | −14.80% | +222.73% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $3.89 | −15.80% | +183.94% | +113.74% |
| VHI.TO | Vitalhub Corp. | 8.11 CAD | +16.69% | −14.99% | −36.39% |
| 3733.T | Software Service, Inc. | 12,520.00 JPY | +10.50% | −6.64% | −14.23% |
| IFRX | InflaRx N.V. | $2.42 | +43.20% | +122.02% | +142.00% |
| OPT.L | Optima Health plc | 240.50 GBP | +1.48% | +20.85% | +9.32% |
| VMD | Viemed Healthcare, Inc. | $9.33 | −21.73% | +29.22% | +29.94% |
| SABS | SAB Biotherapeutics, Inc. | $3.88 | +12.46% | +2.92% | +83.02% |
| 219A.T | HEARTSEED INC | 2,435.00 JPY | +48.48% | +34.90% | −30.13% |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% |
| IKT | Inhibikase Therapeutics, Inc. | $2.49 | +7.79% | +27.69% | +39.11% |
| ABEO | Abeona Therapeutics Inc. | $6.01 | −0.17% | +13.18% | −12.90% |
| PRQR | ProQR Therapeutics N.V. | $2.35 | +33.52% | +18.09% | +6.33% |
| RCEL | AVITA Medical, Inc. | $10.59 | +129.72% | +205.19% | +133.77% |
| AVH.AX | AVITA Medical, Inc. | 2.87 AUD | +117.05% | +160.45% | +106.12% |
| SBS.DE | Stratec SE | 22.85 EUR | +11.46% | +3.39% | −16.91% |
| SMTI | Sanara MedTech Inc. | $34.65 | +30.07% | +50.00% | +2.09% |
| OBIO | Orchestra BioMed Holdings, Inc. | $5.26 | +36.27% | +22.04% | +85.21% |
| IRD | Opus Genetics, Inc. | $3.80 | +11.44% | +79.25% | +216.67% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | 0.00% | +40.76% | +28.86% |
| RNAC | Cartesian Therapeutics, Inc. | $10.19 | +33.20% | +50.74% | −4.09% |
| TMCI | Treace Medical Concepts, Inc. | $4.72 | +17.71% | +88.80% | −36.39% |
| FATE | Fate Therapeutics, Inc. Common Stock | $2.57 | +10.78% | +159.60% | +129.46% |
| TLSI | TriSalus Life Sciences, Inc. | $4.93 | +13.86% | −19.18% | −3.33% |
| MED.DE | MEDICLIN Aktiengesellschaft | 5.45 EUR | +31.64% | +51.39% | +75.81% |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% |
| TTRX | Turn Therapeutics Inc. | $9.63 | +25.06% | +105.33% | +37.57% |
| ANIK | Anika Therapeutics, Inc. | $21.68 | +43.10% | +131.87% | +136.17% |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% |
| PYXS | Pyxis Oncology, Inc. | $3.34 | +14.78% | +190.43% | +145.59% |
| AFP.AX | AFT Pharmaceuticals Limited | 3.60 AUD | −8.86% | +20.00% | +50.00% |
| TSTL.L | Tristel plc | 425.00 GBP | +1.19% | −2.84% | +19.76% |
| WHWK | Whitehawk Therapeutics, Inc. | $4.84 | +31.52% | +98.36% | +167.40% |
| ALXO | ALX Oncology Holdings Inc. | $1.98 | −0.50% | +72.17% | +65.00% |
| 6078.T | Value HR Co.,Ltd. | 1,631.00 JPY | +4.48% | +6.53% | +6.39% |
| ELDN | Eledon Pharmaceuticals, Inc. | $3.35 | −1.47% | +106.79% | +29.84% |
| CGEN | Compugen Ltd. | $2.84 | +25.66% | +83.23% | +93.20% |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% |
| ELMD | Electromed, Inc. | $31.77 | −19.53% | +15.99% | +28.26% |
| ALEC | Alector, Inc. | $2.46 | +61.84% | +60.78% | +2.50% |
| PRN.TO | Profound Medical Corp. | 9.90 CAD | −3.60% | −6.16% | +59.16% |
| SLGL | Sol-Gel Technologies Ltd. | $79.43 | −4.38% | +88.45% | +261.87% |
| PROF | Profound Medical Corp. | $7.11 | −1.93% | −7.18% | +57.30% |
| NERV | Minerva Neurosciences, Inc. | $5.43 | +26.87% | +38.52% | +129.11% |
| ADAG | Adagene Inc. | $3.85 | +3.22% | +109.24% | +75.80% |
| 6823.T | Rion Co., Ltd. | 3,355.00 JPY | +3.23% | +28.29% | +29.62% |
| MGNX | MacroGenics, Inc. Common Stock | $4.04 | +4.94% | +150.93% | +134.88% |
| ALMDT.PA | Median Technologies SA | 4.57 EUR | +15.84% | +3.98% | +90.42% |
| OSUR | OraSure Technologies, Inc. | $3.71 | −7.71% | +55.88% | +11.08% |
| IPHA | Innate Pharma S.A. | $2.16 | +28.57% | +18.68% | +2.86% |
| ACB | Aurora Cannabis Inc. | $4.00 | +47.06% | −7.83% | −24.95% |
| ACB.TO | Aurora Cannabis Inc. | 5.54 CAD | +44.65% | −6.73% | −24.93% |
| CRDL | Cardiol Therapeutics Inc. | $2.14 | +78.33% | +115.29% | +91.07% |
| CRDL.TO | Cardiol Therapeutics Inc. | 2.97 CAD | +74.71% | +118.38% | +90.38% |
| SPL.AX | Starpharma Holdings Limited | 0.73 AUD | −2.03% | +98.63% | +437.04% |
| 4548.T | Seikagaku Corporation | 719.00 JPY | −5.27% | +2.45% | +13.11% |
| TTX.AX | Tetratherix Limited | 6.43 AUD | −14.83% | +94.85% | +56.83% |
| 4577.T | Daito Pharmaceutical Co.,Ltd. | 1,380.00 JPY | +6.73% | +3.16% | +14.45% |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% |
| CLN.WA | Celon Pharma S.A. | 22.20 PLN | +5.21% | +8.82% | −3.06% |
| 6062.T | Charm Care Corporation | 1,394.00 JPY | +0.29% | +6.98% | +33.46% |
| DTIL | Precision BioSciences, Inc. | $8.49 | +18.41% | +107.07% | +69.46% |
| XLY.TO | Auxly Cannabis Group Inc. | 3.13 CAD | +19.92% | +2058.62% | +1919.35% |
| STIM | Neuronetics, Inc. | $3.00 | +60.43% | +108.33% | −10.71% |
| UTMD | Utah Medical Products, Inc. | $70.89 | −0.10% | +26.08% | +17.76% |
| IMUX | Immunic, Inc. | $16.49 | +23.61% | +182.85% | +92.87% |
| HITI | High Tide Inc. | $2.52 | +22.33% | −10.00% | −30.00% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.30 | +24.38% | +43.58% | +7.93% |
| ORMP | Oramed Pharmaceuticals Inc. | $5.34 | +28.06% | +96.84% | +159.19% |
| ABOS | Acumen Pharmaceuticals, Inc. | $2.99 | +31.14% | +48.02% | +115.11% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | 847.00 JPY | +40.00% | +44.79% | +75.00% |
| STIL.ST | Stille AB | 225.00 SEK | −5.06% | +16.58% | −4.26% |
| DERM | Journey Medical Corporation | $7.55 | +19.57% | +1.28% | +0.87% |
| CUE | Cue Biopharma, Inc. | $28.85 | −4.63% | +185.36% | +16.42% |
| ANTX | AN2 Therapeutics, Inc. | $5.53 | +17.66% | +398.20% | +385.09% |
| AOTI.L | AOTI, Inc. | 142.50 GBP | +35.71% | +418.18% | +159.09% |
| ACOG | Alpha Cognition Inc. | $9.41 | +11.89% | +44.77% | +14.20% |
| ICE.WA | Medinice S.A. | 72.30 PLN | −6.35% | +330.36% | +595.19% |
| PDEX | Pro-Dex, Inc. | $63.84 | +13.31% | +69.25% | +40.31% |
| 096760.KS | JW Holdings Corporation | 4,050.00 KRW | +12.81% | +21.23% | +28.35% |
| KRRO | Korro Bio, Inc. | $13.68 | +30.29% | +69.94% | −36.61% |
| MSCL.TO | Satellos Bioscience Inc. | 13.08 CAD | −2.10% | +55.71% | +81.67% |
| PLX | Protalix BioTherapeutics, Inc. | $2.48 | +6.44% | +42.53% | +55.00% |
| LIK.DE | LIMES Schlosskliniken AG | 570.00 EUR | −0.87% | +58.33% | +70.66% |
| AMWL | American Well Corporation | $11.92 | +7.48% | +145.77% | +71.51% |
| MSLE | Satellos Bioscience Inc. | $9.36 | −1.06% | +50.87% | +77.27% |
| NKTX | Nkarta, Inc. | $2.63 | +18.47% | +40.64% | +17.41% |
| 5592.T | Kusurinomadoguchi, Inc. | 2,721.00 JPY | +12.76% | +2.69% | −27.59% |
| XGN | Exagen Inc. | $7.67 | +72.36% | +26.99% | −19.69% |
| PEB.AX | Pacific Edge Limited | 0.20 AUD | −9.09% | +25.00% | +60.00% |
| MYX.AX | Mayne Pharma Group Limited | 3.15 AUD | +19.32% | −1.25% | −37.38% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | 2,892.00 JPY | +4.82% | +10.10% | +21.78% |
| 008490.KS | Suheung Co., Ltd. | 22,050.00 KRW | +12.44% | +2.56% | −24.62% |
| CARA.ST | Carasent AB (publ) | 25.25 SEK | +1.00% | −5.78% | −10.62% |
| 4320.T | CE Holdings Co.,Ltd. | 1,652.00 JPY | −3.05% | +57.63% | +139.84% |
| MOLN | Molecular Partners AG | $4.45 | +16.19% | +5.45% | +18.67% |
| KZIA | Kazia Therapeutics Limited | $14.60 | +15.05% | +192.00% | +86.94% |
| VME.DE | Viromed Medical AG | 6.50 EUR | −15.03% | +71.96% | +85.71% |
| FOCL | EDAP TMS S.A. | $4.41 | −27.23% | +29.71% | +179.11% |
| NYKD.OL | Nykode Therapeutics AS | 4.64 NOK | +45.68% | +96.94% | +204.86% |
| OKUR | OnKure Therapeutics, Inc. | $3.80 | −3.80% | +28.38% | +35.71% |
| 3939.T | Kanamic Network Co.,LTD | 520.00 JPY | +3.59% | +1.56% | +6.05% |
| ENE.WA | Centrum Medyczne ENEL-MED S.A. | 20.00 PLN | −0.99% | +11.11% | +16.28% |
| ASRT | Assertio Holdings Inc | $23.50 | 0.00% | +157.11% | +103.46% |
| NRXP | NRx Pharmaceuticals, Inc. | $3.46 | −2.26% | +32.06% | +34.11% |
| EQ | Equillium, Inc. | $2.36 | +1.72% | +54.25% | +23.56% |
| MRC.WA | Mercator Medical S.A. | 60.40 PLN | +18.43% | +52.53% | +35.88% |
| BICO.ST | BICO Group AB (publ) | 19.92 SEK | +36.25% | −1.19% | −17.00% |
| GENO.ST | Genovis AB (publ.) | 20.15 SEK | +2.81% | −7.36% | −16.91% |
| V5P.F | Vytrus Biotech, S.A. | 17.60 EUR | +1.73% | +67.62% | +225.93% |
| LOVE.TO | Cannara Biotech Inc. | 1.99 CAD | +5.29% | +11.80% | +11.80% |
| 4599.T | StemRIM | 350.00 JPY | +21.53% | +32.08% | +14.75% |
| PAX.ST | Paxman AB (publ) | 57.50 SEK | +26.37% | +2.68% | −21.45% |
| MXCT | MaxCyte, Inc. | $1.31 | +24.76% | −15.48% | −6.43% |
| HURA | TuHURA Biosciences, Inc. | $2.13 | 0.00% | +184.00% | −26.55% |
| NYR.AX | Nyrada Inc. | 0.76 AUD | +40.74% | −35.86% | +210.20% |
| 7600.T | Japan Medical Dynamic Marketing, INC. | 810.00 JPY | −10.00% | +67.91% | +59.26% |
| SEDANA.ST | Sedana Medical AB (publ) | 12.02 SEK | +23.92% | +12.13% | −22.05% |
| MVIR.ST | Medivir AB (publ) | 2.08 SEK | +14.29% | +351.19% | +4.73% |
| XI3.F | Bioceltix S.A. | 20.40 EUR | +7.59% | −16.22% | −28.67% |
| 3649.T | FINDEX Inc. | 860.00 JPY | −0.58% | −6.01% | +4.84% |
| CPIX | Cumberland Pharmaceuticals Inc. | $8.97 | +69.86% | +125.38% | +163.82% |
| PMN | ProMIS Neurosciences, Inc. | $14.46 | −0.41% | +102.52% | +9.13% |
| VANI | Vivani Medical, Inc. | $1.42 | +8.02% | +11.42% | +15.98% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| BMEA | Biomea Fusion, Inc. | $1.71 | +36.80% | +27.61% | −8.06% |
| 4538.T | Fuso Pharmaceutical Industries,Ltd. | 2,310.00 JPY | +1.90% | +1.94% | +11.15% |
| ANIX | Anixa Biosciences, Inc. | $3.61 | +2.41% | +14.08% | +22.20% |
| CRAD-B.ST | C-Rad AB (publ) | 35.30 SEK | −4.08% | +11.00% | +6.49% |
| SCP.WA | Scope Fluidics S.A. | 140.20 PLN | +19.83% | +0.29% | −9.90% |
| EMV.AX | EMVision Medical Devices Ltd | 1.73 AUD | +11.61% | −2.26% | −13.93% |
| SDI.AX | SDI Ltd | 1.40 AUD | 0.00% | +51.08% | +60.41% |
| MDP.TO | Medexus Pharmaceuticals Inc. | 5.18 CAD | +7.02% | +67.64% | +66.56% |
| QUCY | Quantum Cyber N.V. | $1.38 | +26.15% | +18.53% | −15.12% |
| SEER | Seer, Inc. | $2.02 | −5.61% | +10.99% | −1.94% |
| SYNACT.ST | SynAct Pharma AB | 19.66 SEK | +12.99% | −12.43% | +10.82% |
| 3544.T | Satudora Holdings Co.,Ltd. | 1,249.00 JPY | −0.64% | +54.37% | +51.42% |
| ALECR.PA | Eurofins-Cerep SA | 17,700.00 EUR | +8.59% | −0.56% | −3.80% |
| HBP.TO | Helix BioPharma Corp. | 1.94 CAD | +33.79% | −19.17% | +46.97% |
| LNSR | LENSAR, Inc. | $8.65 | +61.68% | −25.50% | −29.04% |
| LUNG | Pulmonx Corporation | $2.50 | +100.00% | +8.70% | +34.41% |
| 7634.T | Hoshi Iryo-Sanki Co., Ltd. | 5,300.00 JPY | 0.00% | +4.57% | +14.22% |
| 4575.T | CanBas Co., Ltd. | 840.00 JPY | +23.17% | +2.56% | −30.98% |
| PYPD | PolyPid Ltd. | $5.11 | +36.27% | +17.47% | +49.42% |
| PTHS | Pelthos Therapeutics Inc. | $26.78 | −3.56% | −9.07% | +12.90% |
| NANOFH.HE | Nanoform Finland Oyj | 0.96 EUR | +9.34% | −18.64% | +15.66% |
| ILA.AX | Island Pharmaceuticals Limited | 0.45 AUD | +18.42% | +3.45% | +109.30% |
| 004080.KS | Shinhung Co., Ltd | 14,080.00 KRW | +0.28% | +0.57% | +2.54% |
| ATRA | Atara Biotherapeutics, Inc. | $9.38 | +20.10% | −47.21% | −24.05% |
| NANOFS.ST | Nanoform Finland Oyj | 10.94 SEK | +15.40% | −15.06% | +19.56% |
| ACRV | Acrivon Therapeutics, Inc. | $2.08 | +35.06% | −15.45% | +52.94% |
| BIOPOR.CO | BioPorto A/S | 1.24 DKK | +2.48% | +19.00% | −3.13% |
| ECOR | electroCore, Inc. | $10.35 | +69.95% | +127.47% | +86.49% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | 68.60 SEK | +3.94% | +37.75% | +15.88% |
| ICCC | ImmuCell Corporation | $10.02 | −10.85% | +69.26% | +64.26% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | 1,145.00 JPY | +12.48% | +7.77% | −23.84% |
| EAH.L | ECO Animal Health Group plc | 99.00 GBP | +1.54% | −6.60% | +34.69% |
| RLYB | Rallybio Corporation | $16.88 | +4.49% | +198.44% | +257.63% |
| 194A.T | WOLVES HAND CO LTD | 1,877.00 JPY | +48.73% | +8.18% | +102.92% |
| NANEXA.ST | Nanexa AB (publ) | 4.63 SEK | +14.46% | +15.03% | +100.43% |
| ATHE | Alterity Therapeutics Limited | $4.78 | +4.60% | +51.27% | −4.40% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | 6.40 SEK | +4.23% | +220.80% | +78.27% |
| BB1.AX | BLINKLAB FPO [BB1] | 0.80 AUD | +23.26% | −3.64% | +47.22% |
| CREO.L | Creo Medical Group PLC | 12.88 GBP | −5.50% | +26.85% | −1.90% |
| CING | Cingulate Inc. | $5.40 | +19.21% | +23.29% | +29.19% |
| 7792.T | Colan Totte.Co.,Ltd. | 1,484.00 JPY | +2.91% | +0.61% | +6.32% |
| ACET | Adicet Bio, Inc. | $8.95 | +9.15% | +1.47% | −26.01% |
| POLB.L | Poolbeg Pharma PLC | 8.60 GBP | +36.51% | +120.51% | +164.62% |
| HIGH.DE | Cantourage Group SE | 6.00 EUR | +5.63% | +80.72% | +51.90% |
| OBI.L | Ondine Biomedical Inc. | 11.75 GBP | −14.55% | +34.29% | −24.19% |
| INIFY.OL | INIFY Laboratories AB | 7.95 NOK | −3.05% | +65.63% | +44.55% |
| ATH.AX | Alterity Therapeutics Limited | 0.52 AUD | +0.98% | +14.44% | −14.17% |
| APLM | Apollomics, Inc. | $26.20 | +43.80% | +35.75% | +320.55% |
| OSTX | OS Therapies Incorporated | $1.65 | +10.00% | +23.13% | −34.00% |
| LONA | LeonaBio, Inc. | $7.81 | +12.05% | +12.21% | +95.25% |
| NRXS | NeurAxis, Inc. | $5.96 | −8.73% | +33.63% | +146.28% |
| MNOV | MediciNova, Inc. | $1.48 | +11.28% | +11.28% | +10.45% |
| KOO.L | Kooth plc | 146.00 GBP | −3.63% | +26.96% | −7.59% |
| FBIOP | Fortress Biotech, Inc. | $18.40 | −1.92% | +81.10% | +131.74% |
| ALTHX.PA | THX Pharma Société Anonyme | 4.18 EUR | +5.16% | +83.92% | +73.96% |
| 4875.T | MediciNova, Inc. | 229.00 JPY | +9.57% | +8.53% | +11.17% |
| 7702.T | JMS Co.,Ltd. | 459.00 JPY | +1.32% | +5.64% | +6.20% |
| ZLNA.OL | Zelluna ASA | 21.70 NOK | −2.25% | +55.00% | +56.57% |
| SAR.L | Sareum Holdings plc | 37.00 GBP | +76.19% | +117.65% | +76.19% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +19.09% | +6.50% | −7.75% |
| INCR | InterCure Ltd. | $5.95 | +546.74% | +477.67% | +265.03% |
| 9341.T | GENOVA, Inc. | 634.00 JPY | −0.94% | +13.48% | +1.56% |
| INMB | INmune Bio Inc. | $2.45 | +42.98% | +58.77% | +19.56% |
| RNXT | RenovoRx, Inc. | $1.49 | +64.28% | +78.44% | +61.08% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | 311.00 JPY | +15.61% | +9.43% | +1.97% |
| SER | Serina Therapeutics, Inc. | $2.63 | +27.05% | +26.56% | −47.29% |
| AVE.AX | Avecho Biotechnology Limited | 0.02 AUD | +20.00% | +152.63% | +300.00% |
| BOLD | Boundless Bio, Inc. | $2.92 | +18.02% | +138.93% | +155.70% |
| 2934.T | J Frontier Co.,Ltd. | 1,944.00 JPY | +7.11% | +47.61% | −2.11% |
| TLPH | Talphera, Inc. | $1.26 | −3.08% | +8.62% | +133.33% |
| R0L.F | J Frontier Co.,Ltd. | 10.30 EUR | +10.75% | −44.02% | −44.02% |
| MYO | Myomo, Inc. | $1.53 | +60.21% | +54.55% | +36.61% |
| INKT | MiNK Therapeutics, Inc. | $11.79 | +11.86% | +6.03% | −26.22% |
| 9265.T | Yamashita Health Care Holdings,Inc. | 3,745.00 JPY | +7.61% | +16.27% | +24.40% |
| XLO | Xilio Therapeutics, Inc. | $9.05 | −1.09% | −3.81% | −5.63% |
| 7133.T | HYUGA PRIMARY CARE Co.,Ltd. | 1,300.00 JPY | +5.95% | +15.08% | −0.72% |
| 4524.T | Morishita Jintan Co., Ltd. | 2,241.00 JPY | +0.86% | +4.83% | +4.22% |
| COCH | Envoy Medical, Inc. | $0.74 | +8.39% | +5.75% | −37.09% |
| 4896.T | K Pharma,Inc. | 763.00 JPY | +6.71% | +13.88% | +14.56% |
| SCYX | SCYNEXIS, Inc. | $5.67 | +56.20% | +787.32% | +579.04% |
| ALTHE.PA | Theraclion SA | 0.63 EUR | +6.55% | +3.93% | −22.30% |
| ALSMA.PA | S.M.A.I.O S.A. | 7.60 EUR | −2.56% | +23.58% | +14.29% |
| NTRB | Nutriband Inc. | $4.50 | +52.28% | +1.58% | −29.80% |
| PRPO | Precipio, Inc. | $30.41 | +34.12% | +27.64% | +99.25% |
| ATX.AX | Amplia Therapeutics Limited | 0.15 AUD | +11.54% | −14.71% | −14.71% |
| EPIS-B.ST | Episurf Medical AB (publ) | 0.08 SEK | +37.70% | +90.12% | +71.52% |
| OHGR.L | One Health Group Plc | 292.50 GBP | +10.38% | +16.53% | +17.03% |
| 4572.T | Carna Biosciences, Inc. | 402.00 JPY | +37.67% | 0.00% | +81.90% |
| MOB.ST | Moberg Pharma AB (publ) | 10.70 SEK | +9.52% | +4.49% | +32.92% |
| 9218.T | Mental Health Technologies Co.,Ltd. | 778.00 JPY | +5.14% | −4.31% | −7.41% |
| 4597.T | Solasia Pharma K.K. | 30.00 JPY | +3.45% | +7.14% | −18.92% |
| ENP.AX | Entropy Neurodynamics Limited | 0.04 AUD | +17.14% | +28.12% | +10.81% |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% |
| MLSS | Milestone Scientific Inc. | $0.54 | +25.44% | +86.00% | −10.10% |
| 3628.T | Data Horizon Co.,Ltd. | 592.00 JPY | −0.84% | +19.60% | +7.64% |
| ALGS | Aligos Therapeutics, Inc. | $7.51 | +76.71% | −17.74% | −33.72% |
| IMMU.ST | Mendus AB (publ) | 7.10 SEK | +2.60% | +23.05% | −4.57% |
| CLBIO.ST | Corline Biomedical AB | 18.85 SEK | +6.80% | +8.96% | +45.56% |
| ELUT | Elutia Inc. | $1.00 | +9.29% | +55.52% | −54.75% |
| 9340.T | ASO International, Inc. | 714.00 JPY | +0.28% | −1.79% | +0.18% |
| NEPH | Nephros, Inc. | $4.05 | +15.71% | −14.74% | 0.00% |
| CTE.AX | Cryosite Limited | 1.25 AUD | +4.17% | +25.00% | +56.25% |
| ONCIN.OL | Oncoinvent ASA | 85.00 NOK | −2.07% | +80.85% | +10.90% |
| ALCOX.PA | Nicox S.A. | 0.38 EUR | +0.79% | +21.76% | +2.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.